Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Finasteride improves heart function and repairs damage after heart attack in mice.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Botulinum toxin may help treat hair loss but needs more research for effectiveness and cost concerns.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Hidradenitis suppurativa improves with antiandrogen therapy.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.